Methyl prednisolone

ApprovedSmall molecule

NNucitec

Methyl prednisolone is one of 207 small molecule programs targeting Vasculitis. It is currently in Approved.

Indications

Total Trials

Active Trials

206

Competitors

Pipeline

Status by Indication[3][1]

Indication

VasculitisActive, not recruiting

LymphomaActive, not recruiting

HistiocytosisActive, not recruiting

Lupus NephritisActive, not recruiting

Heart DiseaseActive, not recruiting

NeuropathyActive, not recruiting

VasculitisPhase 2/Phase 3

Active, not recruiting

LymphomaPhase 3

Active, not recruiting

HistiocytosisPhase 1/Phase 2

Active, not recruiting

Lupus NephritisPhase 3

Active, not recruiting

Heart DiseaseApproved

Active, not recruiting

NeuropathyPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

1774 competitors in Lymphoma

#DrugCompanyPhaseTrials

Methyl prednisolone

NNucitec

Approved

1 2

Blenoxane

SSequus Pharmaceuticals

Preclinical

25 3

Zofran

Novartis

Preclinical

2 4

Norvir

AbbVie

Preclinical

1 5

Wellcovorin

GGlaxo Dba Glaxosmithkline

Preclinical

4 6

Emend

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 7

Kenalog

BBausch Health Americas, Inc.

Preclinical

1 8

Nuvigil

NNuvo Research GmbH

Preclinical

1 9

Decadron

QQuince Therapeutics S.p.A.

Preclinical

—10

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Neuropathy1 trial

Traumatic Optic Neuropathy Treatment Trial (TONTT)

Completed·TTehran University of Medical Sciences·Phase 1/2·NCT01783847·117 enrolled

Heart Disease1 trial

High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease

Unknown status·—·Phase 4·NCT05103397·75 enrolled

Vasculitis1 trial

Plasma Exchange for Renal Vasculitis

Terminated·—·Phase 2/3·NCT01408836·150 enrolled

Lupus Nephritis1 trial

Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis

Terminated·IImperial College London·Phase 3·NCT01773616·24 enrolled

Lymphoma1 trial

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Completed·MM.D. Anderson Cancer Center·Phase 3·NCT00577993·210 enrolled

5 more indications

Clinical Trial1 trial

PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial

Completed·KKristian Kiim Jensen·N/A·NCT02594241·42 enrolled

Treatment1 trial

Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment

Unknown status·NNucitec·Phase 2/3·NCT00977444·114 enrolled

Histiocytosis1 trial

Treatment of Familiar Lymphohistiocytosis

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 1/2·NCT02472054·29 enrolled

Complication1 trial

Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications

Enrolling by invitation·SSana'a University·Phase 3·NCT07317596·40 enrolled

Pediatric Patients1 trial

Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients

Completed·KKonya City Hospital·N/A·NCT07175623·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Methyl prednisolone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Methyl prednisolone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Methyl prednisolone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Nucitec company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: NNucitec

Methyl prednisolone

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Neuropathy1 trial

Heart Disease1 trial

Vasculitis1 trial

Lupus Nephritis1 trial

Lymphoma1 trial

Clinical Trial1 trial

Treatment1 trial

Histiocytosis1 trial

Complication1 trial

Pediatric Patients1 trial

References

Drug Info

Quick Facts

Related News